$33,715,767
AIRWAY TRANSCRIPTOMIC RESPONSES TO COVID-19 ILLNESSES IN THE HUMAN EPIDEMIOLOGY AND RESPONSE TO SARS-COV-2 (HEROS) COHORT
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Study airway transcriptomic responses to COVID-19 in a human cohort to understand disease mechanisms and immune responses.
Advances understanding of COVID-19 pathogenesis and may inform therapeutic development and pandemic preparedness strategies.
Drives demand for genomic sequencing services, bioinformatics platforms, and laboratory reagents for transcriptomic analysis.
Strengthens U.S. biomedical research capabilities in infectious disease genomics, an area of strategic scientific competition.
Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002206.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier ASST_NON_UM1AI151958_075.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.